# Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.

> **NCT07666113** · NA · RECRUITING · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 240 (estimated)

## Conditions studied

- Alzheimer's Disease (AD)

## Interventions

- **DIAGNOSTIC_TEST:** ptau217

## Key facts

- **NCT ID:** NCT07666113
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-26
- **Primary completion:** 2030-04
- **Final completion:** 2038-04
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07666113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07666113, "Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07666113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*